Ayman Saad
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant (NCT04312789) | Ayman Saad | 2022-12-01 |
Track Ayman Saad automatically
Every clearance here is in the API, with alerts when new ones post.